Alto Neuroscience, Inc. (ANRO)
20.76
+0.31
(+1.52%)
USD |
NYSE |
May 20, 16:00
20.76
0.00 (0.00%)
After-Hours: 20:00
Alto Neuroscience Free Cash Flow : -62.86M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 17.80B |
| Eli Lilly & Co. | 10.37B |
| NRX Pharmaceuticals, Inc. | -14.93M |
| LB Pharmaceuticals, Inc. | -50.43M |
| ANI Pharmaceuticals, Inc. | 182.81M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.09M |
| Cash from Investing (Quarterly) | -0.556M |
| Cash from Financing (Quarterly) | 114.94M |
| Free Cash Flow Per Share (Quarterly) | -0.8405 |
| Free Cash Flow to Equity (Quarterly) | -26.90M |
| Free Cash Flow to Firm (Quarterly) | -27.10M |
| Free Cash Flow Yield | -10.18% |